Osama El-Mishawy,MD
Transcript of Osama El-Mishawy,MD
Management of UTI
by
Osama El-Mishawy,MD
Head of Medicine & Nephrology
Depart. Minia University
Case Study
35-year-old woman has experienced urinary frequency with dysuria for the past 4 days. On physical examination
she has no flank pain or tenderness.
Urinalysis reveals sp. gr. 1014, pH 7.5, no glucose, no protein, no blood, nitrite positive, and many WBC's. She has a serum creatinine of 0.9 mg/dL.
Which of the following is the most likely diagnosis?
A-Lupus nephritis B-Urinary tract lithiasis C- Acute bacterial cystitis
D-PSGN E-Urothelial carcinoma
Case Study
A-Lupus nephritis B-Urinary tract lithiasis
C-Acute bacterial cystitis D-PSGN E-Urothelial carcinoma
(C) CORRECT. These are features of acute
inflammation. There are no casts, because the infection involves the bladder, though such an infection could ascend to produce pyelonephritis. Urinary tract
infections are more common in women because of the shorter urethra
Urinary tract infections
Asymptomatic bacteriuria
Acute cystitis
Acute pyelonephritis
Uncomplicated / complicated UTI
Epidemiology of UTI
UTI is more common in females.(1-2% of young non pregnant women).
40% of females will have a symptomatic UTI in their life
time.
In men: prevalence is 0.04%.
Incidence of UTI increases in old age.(10% of men & 20% of women)
Risk factors for UTI
in females: pregnancy, spermicidal contraceptives, diaphragm, estrogen deficiency, diabetes.
In males:
lack of circumcision, prostatic hypertrophy, catheter.
in both :
old age , obstruction, vesicoureteric reflux, instrumentation, neurogenic bladder, renal transplantation.
Infecting organisms
E.coli Proteus
Klebsiella Pseudomonas
Enterobacter Enterococci
Staphylococci Candida
Pathogenesis of UTI
Host defences:
Urinary bladder is usually resistant to bacterial
colonisation.
Bacteria accessing the bladder are eliminated by:
flushing mechanism
urine inhibitors (PH)
uroepithelial defences (cytokines,PMNs)
Pathogenesis of UTI
Periutheral area & urethra are colonised by bacteria.
Bacteria enter bladder in susceptable host.
Adherence properties enable pathogens to colonise bladder.
Pathogens attach to uroepithelial mucosa secretion of cytokines recruitment of PMNs inflammation.
Pathogens may ascend through ureter to kidney pyelonephritis.
Clinical presentation of UTI
Asymptomatic bacteriuria:
Common in females & elderly.
25% develop symptomatic UTI .
25% clear spontaneously.
Spontaneous cure & reinfection are common.
Cystitis:
Frequency, dysurea , urgency.
Suprapubic discomfort +/- tenderness.
Fever is often absent.
Clinical presentation of UTI
Acute pyelonephritis:
Fever, abdominal pain, vomiting.
Dysuria ,frequency, flank or loin pain.
Flank or loin tenderness.
In elderly: symptoms are often atypical.
Bacteremia is common.
Special situations
UTI in pregnancy:
Asymptomatic bacteriuria occurs in 4-8%.
Of these: 25% develop acute pyelonephritis.
Pyelonephritis in pregnancy predisposes to:
- premature delivery. - low birth weight infant.
- increased newborn mortality.
Special situations
Catheter associated UTI :
Bacteriuria occurs in 10-15% of cathed pts.
All chronicly cathed pts. develop bacteriuria.
Organisms: E.coli, Proteus, Klebsiella, Serratia Pseudomonas, Enterococci, Candida.
Antibiotic resistance is common.
Symptoms are often absent or minimal.
Intermittent cathing reduces infections.
Diagnosis of UTI
Urine dipstick: - leukocyte esterase
- nitrite
Urine microscopy: -WBCs, WBC casts, RBCs - Bacteria ( 1 bact/hpf = significant )
Diagnosis of UTI
Urine culture:
Significant bacteriuria= 100 cfu/ml
Symptoms: 10 cfu/ml = propable infection
(Colony forming unit)
colony-forming unit (CFU) is an estimate of viable bacterial or fungal numbers. Unlike direct microscopic counts where all cells, dead and living, are counted, CFU estimates viable cells.
False negative : antibiotics, antiseptics, urethral syndrome, TB kidney, diuresis.
Natural history of UTI
Treatment of uncomplicated UTI leads to complete resolution and cure.
Recurrences occur in some patients usually within 2-3
months of initial infection.
Recurrent uncomplicated UTI does not lead to chronic renal impairment or failure.
Recurrent complicated UTI may lead to renal failure.
UTI may accelerate progression of underlying renal disease.
Treatment of UTI Acute pyelonephritis:
Mild infections are treated orally. (fluoroquinolones,co-trimoxazole,cefuroxime)
Moderate - severe infections – parenterally trt.
(aminoglycosides, ceftriaxone,aztreonam,tazocin)
Therapy marked decline in bact. count after 48hrs.
Persistent fever, +ve blood culture after 3 days of therapy..suggests obstruction, abscess.
Follow Up urine cultures 2 weeks after end of therapy.
Treatment of UTI
Cystitis:
young females: 3 days of oral therapy (fluoroquinolone,cotrimoxazole,cefuroxime,augm
entin)
In females: symptoms for 7 days or history of previous infection 7 days therapy.
In males : oral therapy for 7-10 days.
Treatment of UTI
Asymptomatic bacteriuria
No urgency to treat – confirm by 2 cultures.
Treatment is indicated in :
- Pregnancy
- Children with VU reflux
- Urinary obstruction
Treatment of UTI
Relapse of infection:
Relapse may be due to : - renal involvement - structural abnormalities - chronic bacterial prostatitis
Relapses need to be treated for 2 weeks.
Obstuction should be corrected .
If uncorrectable obstruction: treatment is prolonged for 4-6 weeks or as required.
The latter group needs Follow Up by monthly cultures and annual assessment of kidneys.
Thank you